×

Menu

Home
About Us
Technology
Pipeline
Partnering
News
Contact
  • Home
  • About Us
  • Technology
  • Pipeline
  • Partnering
  • News
  • Contact

☰

Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer

Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer

by admin | May 11, 2023 | News

ROTTERDAM, May 11, 2023 – Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery and development of next-generation TCR-T therapies against solid tumors, today announces the appointment of Dr. Rachel Abbott as Chief Executive Officer (CEO)....
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board

Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board

by admin | Feb 23, 2023 | News

ROTTERDAM, February 23, 2023 – Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery and development of next-generation TCR-T therapies against solid tumors, today announced the appointment of Prof. Dr. Chiara Bonini to its Scientific...
Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital

Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital

by admin | Oct 28, 2021 | News

ROTTERDAM, October 28, 2021 – Pan Cancer T B.V., a biotech spin-off from the Erasmus MC dedicated to the discovery and development of novel TCR-T therapies against solid tumors, announced today the closing of an extended seed investment round. All current shareholders...
Next Entries »

Recent Posts

  • Laboratory Research Technician – Cell Culture & Immunology
  • Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
  • Pan Cancer T announces that Dr. Helen Tayton-Martin has joined its board as an independent director
  • Pan Cancer T’s potential recognised at MEET2WIN with two awards
  • Extended Partnership with NecstGen

Recent Comments

No comments to show.

Pan Cancer T

Home
About us
Technology
Pipeline
Partnering
News
Contact

Address

Marconistraat 16
3029 AK Rotterdam
The Netherlands 

Follow us

Privacy Statement | Cookies

 

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}